Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Payables (2016 - 2025)

Prothena Corp Public has reported Payables over the past 13 years, most recently at $5.9 million for Q4 2025.

  • Quarterly results put Payables at $5.9 million for Q4 2025, down 24.39% from a year ago — trailing twelve months through Dec 2025 was $5.9 million (down 24.39% YoY), and the annual figure for FY2025 was $5.9 million, down 24.39%.
  • Payables for Q4 2025 was $5.9 million at Prothena Corp Public, down from $10.5 million in the prior quarter.
  • Over the last five years, Payables for PRTA hit a ceiling of $25.4 million in Q4 2023 and a floor of $3.5 million in Q3 2021.
  • Median Payables over the past 5 years was $9.6 million (2022), compared with a mean of $10.5 million.
  • Biggest five-year swings in Payables: skyrocketed 181.02% in 2022 and later tumbled 69.4% in 2024.
  • Prothena Corp Public's Payables stood at $3.7 million in 2021, then skyrocketed by 151.15% to $9.3 million in 2022, then surged by 173.91% to $25.4 million in 2023, then tumbled by 69.4% to $7.8 million in 2024, then decreased by 24.39% to $5.9 million in 2025.
  • The last three reported values for Payables were $5.9 million (Q4 2025), $10.5 million (Q3 2025), and $12.2 million (Q2 2025) per Business Quant data.